Vitamin D in amyotrophic lateral sclerosis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Vitamin D supplementation has been proposed as a potential treatment to delay amyotrophic lateral sclerosis (ALS) progression. The aims of this study were to compare retrospectively vitamin D blood levels in ALS patients with those in healthy subjects; to correlate vitamin D blood levels with clinical functions in patients; and to evaluate whether administration of vitamin D could modify the clinical progression of the disease. Vitamin D blood levels were evaluated in 57ALS patients and in 57 healthy subjects. In the ALS patients the following clinical variables were evaluated every 3 months: Medical Research Council scale (MRC) score; revised ALS functional rating scale (ALSFRS-R) score; forced vital capacity (FVC). Twentyfour patients were treated with high doses of cholecalciferol. No significant differences were found between the vitamin D blood levels in the ALS patients (18.8 ± 12.2) and the healthy subjects (20.7 ± 10.1). The vitamin D levels in the ALS patientsdid not correlate with recorded clinical parameters. No clinical differences in terms of ALSFRS-R, MRC or FVC were found between the treated and the untreated patients over time. In ALS, as in other chronic neurological diseases, levels of vitamin D in blood appeared reduced, but no difference was found between the levels in ALS patients and in healthy subjects. Oral vitamin D supplementation in ALS patients was not associated with better prognosis in comparison with untreated ALS patients. Further prospective controlled studies are needed to clarify the effect of vitamin D on the progression of ALS disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services
Buell, J. S., Dawson-Hughes, B., Scott, T. M., Weiner, D. E., Dallal, G. E., Qui, W. Q., Bergethon, P., Rosenberg, I. H., Folstein, M. F., Patz, S., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181beecb7 · Cited by 288
Camu, W., Tremblier, B., Plassot, C., Alphandery, S., Salsac, C., Pageot, N., Juntas-Morales, R., Scamps, F., Daures, J.-P., & Raoul, C. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.005 · Cited by 95
Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis
Karam, C., Barrett, M. J., Imperato, T., MacGowan, D. J. L., & Scelsa, S. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.01.011 · Cited by 74
Cited by
The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases
Obrenovich, M., Jaworski, H., Tadimalla, T., Mistry, A., Sykes, L., Perry, G., & Bonomo, R. (2020) · Microorganisms · doi:10.3390/microorganisms8050784 · Cited by 62
“Clinically, vitamin D3 reduced the decline in ALSFRS-R score [92].”
BackgroundNutrient effects on motor neurons and the risk of amyotrophic lateral sclerosis
Goncharova, P. S., Davydova, T. K., Popova, T. E., Novitsky, M. A., Petrova, M. M., Gavrilyuk, O. A., Al-Zamil, M., Zhukova, N. G., Nasyrova, R. F., & Shnayder, N. A. (2021) · Nutrients · doi:10.3390/nu13113804 · Cited by 35
“Libonati et al. (2017) conducted a retrospective study involving ALS patients and healthy people.”
BackgroundMorini, E., Portaro, S., Leonetti, D., De Cola, M. C., De Luca, R., Bonanno, M., Quartarone, A., & Calabrò, R. S. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20042923 · Cited by 11
“To date, there is a growing body of evidence [37,38] indicating that the TBS is particularly useful as a complementary technique to BMD for fracture risk assessment in conditions associated with increased fracture risk.”
Background
Metadata
- Authors
- Libonati, L.
- Venue
- Functional Neurology
- Publisher
- Edikta s.r.l.
- Published
- 2017
- Volume
- 32
- Issue
- 1
- Pages
- 35
- ISSN
- 0393-5264 (ISSN-L)
- OpenAlex
- W2734735204
- Cited by
- 35
- References
- 4
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitamin D in amyotrophic lateral sclerosis. https://app.cochat.ai/papers/10.11138/fneur/2017.32.1.035
- The paper
- Libonati, L. (2017). Vitamin D in amyotrophic lateral sclerosis. Functional Neurology. https://doi.org/10.11138/fneur/2017.32.1.035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.